|
|
|
Year ended Dec |
|
Year ended Dec |
|
Year ended Dec |
|
|
|
|
US $ |
|
US $ |
|
US $ |
|
|
General and administrative expenses |
|
|
|
|
|
|
|
|
Employee benefits expenses, including share-based payments |
|
2,778,854 |
|
1,445,110 |
|
1,146,566 |
|
|
Directors’ fees |
|
728,798 |
|
423,051 |
|
380,969 |
|
|
Legal and professional fees |
|
2,762,334 |
|
2,073,317 |
|
1,444,507 |
|
|
Investor and public relations advisory fees |
|
1,283,012 |
|
647,919 |
|
292,949 |
|
|
Other expenses |
|
988,398 |
|
322,753 |
|
312,189 |
|
|
|
|
|
|
|
|
|
|
|
|
|
8,541,396 |
|
4,912,150 |
|
3,577,180 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development costs |
|
|
|
|
|
|
|
|
Employee benefits expenses, including share-based payments |
|
1,468,719 |
|
677,412 |
|
— |
|
|
Contract research organization expenses |
|
22,066,179 |
|
30,445,967 |
|
3,055,421 |
|
|
Chemistry and manufacturing development and other non-clinical development |
|
2,933,475 |
|
2,145,641 |
|
949,466 |
|
|
Other research and development costs |
|
3,006,920 |
|
1,525,795 |
|
676,053 |
|
|
|
|
|
|
|
|
|
|
|
|
|
29,475,293 |
|
34,794,815 |
|
4,680,940 |
|
|
|
|
|
|
|
|
|
|
|
|
|
2017 |
|
2016 |
|
2015 |
|
|
Auditors’ Remuneration |
|
US $ |
|
US $ |
|
US $ |
|
|
Audit Fees |
|
526,170 |
|
871,523 |
|
73,730 |
|
|
Audit-Related Fees |
|
— |
|
— |
|
— |
|
|
Tax Fees |
|
— |
|
— |
|
— |
|
|
Other Fees |
|
— |
|
— |
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total |
|
526,170 |
|
871,523 |
|
73,730 |
|
|
|
|
|
|
|
|
|
|